Guatemala

This video has no sound.

Active

Empowerment through Information

Through its groundbreaking Inform Women, Transform Lives campaign, The Carter Center partners with city leaders worldwide to raise awareness about women’s right to access information and to help cities reach women with valuable information and essential municipal services. 

Access to this information empowers women with a stronger voice, enabling them to participate in public life, utilize public services, and make more informed decisions for themselves, their families, and their communities. In Guatemala, the project has partnered with the city of Guatemala City.

Active

Rule of Law

Legacy

Democracy

Legacy

Human Rights

Legacy

River Blindness

How It Started

Guatemala’s hot and humid coastal plains were among the areas most severely affected by onchocerciasis, also known as river blindness. In 1996, The Carter Center began supporting the national programs of all six endemic countries in the Americas. Guatemala alone accounted for more than 40% of people at risk in the region, with the disease threatening more than 500 of the country’s poorest communities.

Our Work and Methods

Mass administration of the drug Mectizan® (donated by Merck & Co. Inc.) had been the primary strategy for the national elimination program since 1991. But after Guatemala’s public health services were decentralized in 1994, The Carter Center absorbed the River Blindness Foundation, and Guatemala’s Ministry of Health was able to resume treatment activities.

In the four focus areas — Central, Escuinta-Guatemala, Huehuetenango, and Santa Rosa — intensive treatments were followed by post-treatment surveillance and then three years of monitoring, during which black flies and blood samples were tested for evidence of onchocerciasis.

Impacts

  • By 2014, all surveillance and monitoring activities is completed in the four focus areas.
  • In 2016, the World Health Organization confirms that Guatemala has eliminated river blindness.
  • As a result of national leadership and strong partnerships, permanent blindness from the disease no longer is a threat.

This project ended in 2016.

Related Content

Read More
Read More
Read More